Nordic I-O Mission: Networking Event & Panel Discussion “Clinical Strategies in I-O”


Event Details


PLEASE NOTE:  Online registration is closed.  To join, please register on-site.

You are invited to learn more about clinical strategies in Immuno-Oncology (I-O) and meet 12 Nordic Companies advancing a broad range of technologies, preclinical and clinical stage I-O assets.  This event presents a special opportunity to meet, and discuss scientific and other collaboration opportunities in an informal setting.

One-page company descriptions can be downloaded here

To join, please register below.

Program:

2:00 – 2:15 pm           Arrival and Welcome

2:15 – 3:30 pm           Panel Discussion “Clinical Strategies for combination therapies in I-O” 

  • William (Bill) Slichenmyer, Alacrita (Moderator)
  • Gordon Freeman, Professor, Department of Medical Oncology, Dana Farber
  • David Fabrizio, Leader, Cancer Immunotherapy, Foundation Medicine
  • Sridhar Ramaswamy, VP Research and Development, Tesaro
  • Sotirios G. Stergiopoulos, CMO and SVP, Head of Global Medical Affairs Ipsen

3:30 – 5:00 pm          Posters and Networking, Refreshments will be served.

Join this informal event and meet Senior Executives of the following companies:

 

Main Organizers:  Oslo Cancer Cluster and Innovation Norway

Contact Norway: Jutta Heix, Oslo Cancer Cluster, jh@oslocancercluster.no; +47 94 16 30 89 and Hanne Mette Kristensen, Hanne.Mette.Dyrlie.Kristensen@innovasjonnorge.no; +47 971 97 449

Contact USA: Prem Das, premdas@alum.mit.edu; +1 (781) 248 5699

The meeting is co-sponsored by Alacrita.